23ANDME HOLDING CO. |
Market Closed -
Other stock markets
|
After market 04:52:37 pm | |||
| 0.4829 USD | -4.47% |
|
0.489 | +1.26% |
| Apr. 18 | Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup | DJ |
| Apr. 18 | US Equity Markets Close Mixed Thursday | MT |
Presentation Operator MessageOperator (Operator)Good morning, and welcome to the 23andMe's Fis...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including information on customersâ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. The Therapeutics business segment focuses on the use of genetic insights from databases of genetic and phenotypic information to develop novel therapies to improve patientsâ lives. The Therapeutics segment consists of out-licensing of intellectual property associated with identified drug targets and expenses related to therapeutic product candidates.
Calendar
2024-05-22
- Q4 2024 Earnings Release (Projected)
Related indices
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.5055
USD
Average target price
1.425
USD
Spread / Average Target
+181.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -47.14% | 244M | |
| -18.11% | 8.02B | |
| +33.79% | 3.51B | |
| -29.02% | 2.97B | |
| -7.71% | 2.48B | |
| -14.30% | 2.23B | |
| -16.38% | 1.76B | |
| -22.17% | 1.44B | |
| -39.69% | 1.25B | |
| -11.20% | 1.11B |
- Stock Market
- Equities
- ME Stock
- News 23andMe Holding Co.
- Transcript : 23andMe Holding Co., Q4 2022 Earnings Call, May 26, 2022
